Хайлтын үр дүнгүүд - David C. Smith
- 63-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
Small-molecule SMAC mimetics as new cancer therapeutics -н Longchuan Bai, David C. Smith, Shaomeng Wang
Хэвлэсэн 2014Revisão -
2
-
3
-
4
-
5
-
6
-
7
-
8
Combined-Modality Therapy With Gemcitabine and Radiotherapy As a Bladder Preservation Strategy: Results of a Phase I Trial -н Elizabeth C. Kent, Howard M. Sandler, James E. Montie, Cheryl Lee, Joseph M. Herman, Peg Esper, Judith Fardig, David C. Smith
Хэвлэсэн 2004Artigo -
9
-
10
-
11
Detection of CTC Clusters and a Dedifferentiated RNA‐Expression Survival Signature in Prostate Cancer -н Molly Kozminsky, Shamileh Fouladdel, Jae‐Seung Chung, Yugang Wang, David C. Smith, Ajjai Alva, Ebrahim Azizi, Todd M. Morgan, Sunitha Nagrath
Хэвлэсэн 2018Artigo -
12
-
13
-
14
Cerebral oxygenation during paediatric cardiac surgery: identification of vulnerable periods using near infrared spectroscopy -н Piers E.F. Daubeney, David C Smith, S N Pilkington, Robert K. Lamb, James L. Monro, VT Tsang, S.A. Livesey, Steven A. Webber
Хэвлэсэн 1998Artigo -
15
FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignancies -н Vivek Subbiah, Nicholas Iannotti, Martin Gutierrez, David C. Smith, Luis Féliz, Christine Lihou, Chuan Tian, Ian M. Silverman, Tao Ji, Mansoor N. Saleh
Хэвлэсэн 2022Artigo -
16
A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors -н David C. Smith, Rashmi Chugh, Amita Patnaik, Kyriakos P. Papadopoulos, Min Wang, Ann M. Kapoun, Lu Xu, Jakob Dupont, Robert Stagg, Anthony W. Tolcher
Хэвлэсэн 2018Artigo -
17
Randomized clinical trial of a family intervention for prostate cancer patients and their spouses -н Laurel Northouse, Darlene Mood, Ann Schafenacker, James E. Montie, Howard M. Sandler, Jeffrey D. Forman, Maha Hussain, Kenneth J. Pienta, David C. Smith, Trace Kershaw
Хэвлэсэн 2007Artigo -
18
Phase 1/2 dose‐escalation study of a GM‐CSF‐secreting, allogeneic, cellular immunotherapy for metastatic hormone‐refractory prostate cancer -н Celestia S. Higano, John M. Corman, David C. Smith, Arthur S. Centeno, Christopher P. Steidle, Marc Gittleman, Jonathan W. Simons, Natalie Sacks, Junko Aimi, Eric J. Small
Хэвлэсэн 2008Artigo -
19
Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862) -н Deborah Bradley, Dana E. Rathkopf, Rodney L. Dunn, Walter M. Stadler, Glenn Liu, David C. Smith, Роберто Пили, James A. Zwiebel, Howard I. Scher, Maha Hussain
Хэвлэсэн 2009Artigo -
20
A Phase I Dose Escalation and Expansion Study of the Anticancer Stem Cell Agent Demcizumab (Anti-DLL4) in Patients with Previously Treated Solid Tumors -н David C. Smith, Peter D. Eisenberg, Georgy M. Manikhas, Rashmi Chugh, Matthew A. Gubens, Robert Stagg, Ann M. Kapoun, Lu Xu, Jakob Dupont, Branimir I. Šikić
Хэвлэсэн 2014Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Medicine
Internal medicine
Cancer
Oncology
Adverse effect
Biology
Gastroenterology
Prostate cancer
Urology
Cancer research
Surgery
Clinical endpoint
Chemotherapy
Gene
Genetics
Immunotherapy
Biochemistry
Clinical trial
Nausea
Pharmacology
Pathology
Prostate
Tolerability
Chemistry
Pharmacodynamics
Pharmacokinetics
Discontinuation
Phases of clinical research
Randomized controlled trial
Toxicity